OptimizeRx (OPRX) Debt to Equity (2010 - 2026)
OptimizeRx (OPRX) debt to equity from Dec 31, 2010 to Mar 31, 2026. The current OptimizeRx (OPRX) debt to equity is 18.01%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of OptimizeRx (OPRX)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 20.02% | -28.64% |
| 2024 | 28.05% | -2.02% |
| 2023 | 28.63% | N/A |
| 2022 | 0.00% | N/A |
| 2021 | 0.00% | N/A |
| 2021 | 0.00% | N/A |
| 2020 | 0.00% | N/A |
| 2020 | 0.00% | N/A |
| 2019 | 0.00% | N/A |
| 2019 | 0.00% | N/A |
| 2018 | 0.00% | N/A |
| 2017 | 0.00% | N/A |
| 2016 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
| 2014 | 0.00% | N/A |
| 2013 | 0.00% | N/A |
| 2012 | 0.00% | N/A |
| 2011 | 0.00% | -100.00% |
| 2010 | 52.91% | N/A |
Comparison OptimizeRx (OPRX) debt to equity with competitors
OptimizeRx (OPRX) debt to equity is 18.01%.
| Ticker | Name | Debt to Equity | Upside |
|---|---|---|---|
| PHR | Phreesia Inc | 0.79% | -95.62% |
| SY | So-Young International Inc | 2.56% | -85.77% |
| HCTI | Healthcare Triangle Inc | 16.07% | -10.78% |
| CARL | Carlsmed Inc | 16.66% | -7.51% |
| PINC | Premier Inc - Class A | 18.32% | +1.73% |
| VSEE | VSee Health Inc | 20.66% | +14.70% |
| CERT | Certara Inc | 28.76% | +59.69% |
| WAY | Waystar Holding Corp | 37.33% | +107.29% |
| HQY | Healthequity Inc | 45.43% | +152.30% |
| DRIO | DarioHealth Corp | 49.58% | +175.35% |
| GDRX | GoodRx Holdings Inc - Class A | 78.37% | +335.17% |
| RCM | R1 RCM Inc | 78.60% | +336.48% |
| DH | Definitive Healthcare Corp - Class A | 85.34% | +373.88% |
| TBRG | Computer Programs & Systems Inc | 91.70% | +409.21% |
| HCAT | Health Catalyst Inc | 111.02% | +516.49% |
| BTSG | BrightSpring Health Services Inc | 126.20% | +600.79% |
| BTSGU | BrightSpring Health Services Inc | 126.20% | +600.79% |
| SOPH | SOPHiA Genetics SA | 136.63% | +658.74% |
| TEM | Tempus AI Inc - Class A | 195.63% | +986.38% |
| EVH | Evolent Health Inc - Class A | 245.59% | +1263.77% |
| NRC | National Research Corp | 548.48% | +2945.76% |